Role of GLP analogs (and alternatives) in type 2 diabetes: The goal of drug therapy is generally to keep hemoglobin A1C 9% or if glycemic control is inadequate with a combination of the above-mentioned drugs
T1DM is defined as an autoimmune disease, resulting in insulin deficiency
This is why Phase 3 TRIUMPH protocols allow dose reduction rather than discontinuation when a participant approaches a low BMI
The study looking at pioglitazone (PROactive study) failed to show a significant benefit of treatment on the primary composite end points (hazard ratio [HR], 0.90
Many of our patients however, report a noticeable improvement from as little as 2 weeks after their treatment
A common pattern is thigh, abdomen, thigh, abdomen, rotating left and right within each region